Pancreatic Cancer Research

ResearcherRadboud University Medical CenterActive in the last 2 years

Hanne D. Heerkens

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9947-0763; OpenAlex author ID A5041449694. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
55
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 3 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers, 1 trial · 2025: none · 2026: 2 papers

Papers 13

  1. The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analy… Co-author DOI 10.1016/j.ejca.2026.116822↗
  2. The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer. Co-author DOI 10.1016/s1470-2045(25)00714-4↗
  3. Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an i… Co-author DOI 10.1186/s13063-024-08223-5↗
  4. Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): prot… Co-author DOI 10.1186/s13063-024-08295-3↗
  5. Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation … Co-author DOI 10.1186/s13063-022-07036-8↗
  6. A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARC… Co-author DOI 10.1186/s13063-022-06829-1↗
  7. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. Co-author DOI 10.3389/fonc.2021.628155↗
  8. Systematic review on the impact of pancreatoduodenectomy on quality of life in patients with pancreatic cancer. First author DOI 10.1016/j.hpb.2017.11.002↗
  9. Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer. Co-author DOI 10.1016/j.hpb.2017.11.009↗
  10. MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1259/bjr.20170563↗
  11. Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. Co-author DOI 10.1016/j.prro.2016.10.006↗
  12. Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows only limited dosimetric benefit. Co-author DOI 10.1080/0284186x.2016.1257863↗
  13. MRI-based tumor motion characterization and gating schemes for radiation therapy of pancreatic cancer. Co-author DOI 10.1016/j.radonc.2014.03.002↗

Trials 1

  1. Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy Principal investigator NCT06272162↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gert J. Meijer · 10 shared papers, 2014–2026 · strength 1.13
  2. Izaak Quintus Molenaar · 9 shared papers, 2014–2026 · strength 1.09
  3. Hjalmar C. van Santvoort · 8 shared papers, 2014–2026 · strength 1.01
  4. Lois A. Daamen · 7 shared papers, 2018–2026 · strength 0.97
  5. Johanna W. Wilmink · 5 shared papers, 2022–2026 · strength 0.77
  6. Hanneke W.M. van Laarhoven · 5 shared papers, 2022–2026 · strength 0.77
  7. Marc G. Besselink · 5 shared papers, 2022–2026 · strength 0.77
  8. Geertjan van Tienhoven · 5 shared papers, 2017–2024 · strength 0.63
  9. Nadia Haj Mohammad · 4 shared papers, 2022–2024 · strength 0.56
  10. Iris W.J.M. van Goor · 4 shared papers, 2022–2024 · strength 0.56
  11. Robert C. Verdonk · 3 shared papers, 2024–2026 · strength 0.50
  12. Vincent Erwin de Meijer · 3 shared papers, 2024–2026 · strength 0.50
  13. Ignace H. J. T. de Hingh · 3 shared papers, 2024–2026 · strength 0.50
  14. Martijn W.J. Stommel · 3 shared papers, 2024–2026 · strength 0.50
  15. Anna M E Bruynzeel · 3 shared papers, 2022–2026 · strength 0.47
  16. Vincent P. Groot · 3 shared papers, 2018–2024 · strength 0.39
  17. H. M.U. Peulen · 1 shared trial, 2024 · strength 0.39
  18. A. M.E. Bruynzeel · 1 shared trial, 2024 · strength 0.39
  19. M. P.W. Intven · 1 shared trial, 2024 · strength 0.39
  20. J. J. Bosch · 1 shared trial, 2024 · strength 0.39
  21. L. A. Daamen · 1 shared trial, 2024 · strength 0.39
  22. Keith John Roberts · 2 shared papers, 2024 · strength 0.30
  23. Rupaly Pandé · 2 shared papers, 2024 · strength 0.30
  24. Paul C. M. Andel · 2 shared papers, 2024 · strength 0.30
  25. Lodewijk A.A. Brosens · 2 shared papers, 2024 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.